nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—SLC47A2—Mitoxantrone—sarcoma	0.441	0.507	CbGbCtD
Ondansetron—SLC47A1—Mitoxantrone—sarcoma	0.183	0.211	CbGbCtD
Ondansetron—CYP2E1—Dacarbazine—sarcoma	0.0384	0.0442	CbGbCtD
Ondansetron—CYP2E1—Mitoxantrone—sarcoma	0.0298	0.0343	CbGbCtD
Ondansetron—CYP1A2—Dacarbazine—sarcoma	0.0222	0.0256	CbGbCtD
Ondansetron—CYP3A7—Vincristine—sarcoma	0.0213	0.0245	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0213	0.0245	CbGbCtD
Ondansetron—CYP3A4—Thiotepa—sarcoma	0.021	0.0242	CbGbCtD
Ondansetron—CYP2E1—Etoposide—sarcoma	0.0188	0.0216	CbGbCtD
Ondansetron—CYP3A5—Vincristine—sarcoma	0.016	0.0183	CbGbCtD
Ondansetron—CYP3A5—Etoposide—sarcoma	0.0146	0.0168	CbGbCtD
Ondansetron—CYP1A2—Etoposide—sarcoma	0.0109	0.0125	CbGbCtD
Ondansetron—CYP3A4—Mitoxantrone—sarcoma	0.00904	0.0104	CbGbCtD
Ondansetron—HTR1B—dura mater—sarcoma	0.00722	0.361	CbGeAlD
Ondansetron—CYP3A4—Vincristine—sarcoma	0.00622	0.00715	CbGbCtD
Ondansetron—CYP2D6—Doxorubicin—sarcoma	0.00611	0.00703	CbGbCtD
Ondansetron—CYP3A4—Etoposide—sarcoma	0.0057	0.00656	CbGbCtD
Ondansetron—CYP3A4—Doxorubicin—sarcoma	0.00389	0.00447	CbGbCtD
Ondansetron—SLC47A2—tendon—sarcoma	0.00105	0.0525	CbGeAlD
Ondansetron—SLC47A1—myometrium—sarcoma	0.000647	0.0323	CbGeAlD
Ondansetron—SLC47A1—seminal vesicle—sarcoma	0.000584	0.0292	CbGeAlD
Ondansetron—HTR3A—hematopoietic system—sarcoma	0.000565	0.0283	CbGeAlD
Ondansetron—SLC47A1—hematopoietic system—sarcoma	0.000555	0.0278	CbGeAlD
Ondansetron—OPRM1—hematopoietic system—sarcoma	0.000518	0.0259	CbGeAlD
Ondansetron—CYP2C9—mammary gland—sarcoma	0.000455	0.0227	CbGeAlD
Ondansetron—SLC47A1—uterus—sarcoma	0.00042	0.021	CbGeAlD
Ondansetron—CYP3A7—liver—sarcoma	0.000414	0.0207	CbGeAlD
Ondansetron—KCNH2—myometrium—sarcoma	0.000397	0.0198	CbGeAlD
Ondansetron—HTR1A—hematopoietic system—sarcoma	0.000383	0.0191	CbGeAlD
Ondansetron—SLC47A1—tendon—sarcoma	0.000368	0.0184	CbGeAlD
Ondansetron—KCNH2—seminal vesicle—sarcoma	0.000359	0.0179	CbGeAlD
Ondansetron—CYP3A7-CYP3A51P—liver—sarcoma	0.000352	0.0176	CbGeAlD
Ondansetron—KCNH2—hematopoietic system—sarcoma	0.000341	0.017	CbGeAlD
Ondansetron—SLC47A1—testis—sarcoma	0.000304	0.0152	CbGeAlD
Ondansetron—Immune system disorder—Etoposide—sarcoma	0.000298	0.00269	CcSEcCtD
Ondansetron—Hepatic failure—Epirubicin—sarcoma	0.000297	0.00269	CcSEcCtD
Ondansetron—Mediastinal disorder—Etoposide—sarcoma	0.000297	0.00269	CcSEcCtD
Ondansetron—Chills—Etoposide—sarcoma	0.000296	0.00267	CcSEcCtD
Ondansetron—Chest pain—Mitoxantrone—sarcoma	0.000293	0.00265	CcSEcCtD
Ondansetron—Paraesthesia—Thiotepa—sarcoma	0.000293	0.00265	CcSEcCtD
Ondansetron—Anxiety—Mitoxantrone—sarcoma	0.000292	0.00265	CcSEcCtD
Ondansetron—CYP1A2—hematopoietic system—sarcoma	0.000292	0.0146	CbGeAlD
Ondansetron—Discomfort—Mitoxantrone—sarcoma	0.00029	0.00262	CcSEcCtD
Ondansetron—Somnolence—Thiotepa—sarcoma	0.00029	0.00262	CcSEcCtD
Ondansetron—Anaphylactic shock—Vincristine—sarcoma	0.000289	0.00261	CcSEcCtD
Ondansetron—SLC47A1—liver—sarcoma	0.000288	0.0144	CbGeAlD
Ondansetron—OPRM1—testis—sarcoma	0.000284	0.0142	CbGeAlD
Ondansetron—Nervous system disorder—Vincristine—sarcoma	0.000283	0.00256	CcSEcCtD
Ondansetron—CYP3A5—hematopoietic system—sarcoma	0.000281	0.0141	CbGeAlD
Ondansetron—Anaphylactic shock—Mitoxantrone—sarcoma	0.000281	0.00254	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Thiotepa—sarcoma	0.000281	0.00254	CcSEcCtD
Ondansetron—Fatigue—Thiotepa—sarcoma	0.000281	0.00254	CcSEcCtD
Ondansetron—Fatigue—Dactinomycin—sarcoma	0.000279	0.00252	CcSEcCtD
Ondansetron—Pain—Thiotepa—sarcoma	0.000279	0.00252	CcSEcCtD
Ondansetron—Constipation—Thiotepa—sarcoma	0.000279	0.00252	CcSEcCtD
Ondansetron—CYP2C9—hematopoietic system—sarcoma	0.000277	0.0138	CbGeAlD
Ondansetron—Shock—Mitoxantrone—sarcoma	0.000277	0.0025	CcSEcCtD
Ondansetron—Pain—Dactinomycin—sarcoma	0.000276	0.0025	CcSEcCtD
Ondansetron—CYP2E1—seminal vesicle—sarcoma	0.000276	0.0138	CbGeAlD
Ondansetron—Anaphylactoid reaction—Epirubicin—sarcoma	0.000276	0.00249	CcSEcCtD
Ondansetron—Hepatic failure—Doxorubicin—sarcoma	0.000275	0.00249	CcSEcCtD
Ondansetron—Tachycardia—Mitoxantrone—sarcoma	0.000275	0.00248	CcSEcCtD
Ondansetron—Skin disorder—Mitoxantrone—sarcoma	0.000273	0.00247	CcSEcCtD
Ondansetron—Hypotension—Vincristine—sarcoma	0.00027	0.00244	CcSEcCtD
Ondansetron—Feeling abnormal—Thiotepa—sarcoma	0.000268	0.00243	CcSEcCtD
Ondansetron—Feeling abnormal—Dactinomycin—sarcoma	0.000266	0.00241	CcSEcCtD
Ondansetron—Gastrointestinal pain—Thiotepa—sarcoma	0.000266	0.00241	CcSEcCtD
Ondansetron—Ill-defined disorder—Etoposide—sarcoma	0.000266	0.00241	CcSEcCtD
Ondansetron—Gastrointestinal pain—Dactinomycin—sarcoma	0.000264	0.00239	CcSEcCtD
Ondansetron—Hypotension—Mitoxantrone—sarcoma	0.000263	0.00238	CcSEcCtD
Ondansetron—CYP2E1—hematopoietic system—sarcoma	0.000262	0.0131	CbGeAlD
Ondansetron—Paraesthesia—Vincristine—sarcoma	0.000259	0.00235	CcSEcCtD
Ondansetron—Urticaria—Thiotepa—sarcoma	0.000259	0.00234	CcSEcCtD
Ondansetron—KCNH2—cardiac atrium—sarcoma	0.000259	0.0129	CbGeAlD
Ondansetron—Malaise—Etoposide—sarcoma	0.000259	0.00234	CcSEcCtD
Ondansetron—Abdominal pain—Thiotepa—sarcoma	0.000258	0.00233	CcSEcCtD
Ondansetron—Body temperature increased—Thiotepa—sarcoma	0.000258	0.00233	CcSEcCtD
Ondansetron—KCNH2—uterus—sarcoma	0.000257	0.0129	CbGeAlD
Ondansetron—Body temperature increased—Dactinomycin—sarcoma	0.000256	0.00231	CcSEcCtD
Ondansetron—Abdominal pain—Dactinomycin—sarcoma	0.000256	0.00231	CcSEcCtD
Ondansetron—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000255	0.00231	CcSEcCtD
Ondansetron—Paraesthesia—Mitoxantrone—sarcoma	0.000253	0.00229	CcSEcCtD
Ondansetron—Loss of consciousness—Etoposide—sarcoma	0.000252	0.00228	CcSEcCtD
Ondansetron—Dyspnoea—Mitoxantrone—sarcoma	0.000251	0.00227	CcSEcCtD
Ondansetron—Cough—Etoposide—sarcoma	0.00025	0.00226	CcSEcCtD
Ondansetron—Somnolence—Mitoxantrone—sarcoma	0.00025	0.00226	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Vincristine—sarcoma	0.000249	0.00226	CcSEcCtD
Ondansetron—Fatigue—Vincristine—sarcoma	0.000249	0.00225	CcSEcCtD
Ondansetron—Convulsion—Etoposide—sarcoma	0.000248	0.00225	CcSEcCtD
Ondansetron—Pain—Vincristine—sarcoma	0.000247	0.00223	CcSEcCtD
Ondansetron—Constipation—Vincristine—sarcoma	0.000247	0.00223	CcSEcCtD
Ondansetron—Liver function test abnormal—Epirubicin—sarcoma	0.000246	0.00223	CcSEcCtD
Ondansetron—Chest pain—Etoposide—sarcoma	0.000244	0.00221	CcSEcCtD
Ondansetron—Hypokalaemia—Epirubicin—sarcoma	0.000243	0.0022	CcSEcCtD
Ondansetron—Fatigue—Mitoxantrone—sarcoma	0.000243	0.00219	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000242	0.00219	CcSEcCtD
Ondansetron—Discomfort—Etoposide—sarcoma	0.000241	0.00218	CcSEcCtD
Ondansetron—Constipation—Mitoxantrone—sarcoma	0.000241	0.00218	CcSEcCtD
Ondansetron—Pain—Mitoxantrone—sarcoma	0.000241	0.00218	CcSEcCtD
Ondansetron—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00024	0.00217	CcSEcCtD
Ondansetron—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00024	0.00217	CcSEcCtD
Ondansetron—Hypersensitivity—Thiotepa—sarcoma	0.00024	0.00217	CcSEcCtD
Ondansetron—Hypersensitivity—Dactinomycin—sarcoma	0.000238	0.00215	CcSEcCtD
Ondansetron—Gastrointestinal pain—Vincristine—sarcoma	0.000236	0.00214	CcSEcCtD
Ondansetron—Anaphylactic shock—Etoposide—sarcoma	0.000234	0.00212	CcSEcCtD
Ondansetron—Asthenia—Thiotepa—sarcoma	0.000234	0.00211	CcSEcCtD
Ondansetron—Asthenia—Dactinomycin—sarcoma	0.000232	0.0021	CcSEcCtD
Ondansetron—Feeling abnormal—Mitoxantrone—sarcoma	0.000232	0.0021	CcSEcCtD
Ondansetron—Asthma—Epirubicin—sarcoma	0.000231	0.00209	CcSEcCtD
Ondansetron—Pruritus—Thiotepa—sarcoma	0.00023	0.00208	CcSEcCtD
Ondansetron—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00023	0.00208	CcSEcCtD
Ondansetron—Tachycardia—Etoposide—sarcoma	0.000228	0.00207	CcSEcCtD
Ondansetron—Abdominal pain—Vincristine—sarcoma	0.000228	0.00207	CcSEcCtD
Ondansetron—Body temperature increased—Vincristine—sarcoma	0.000228	0.00207	CcSEcCtD
Ondansetron—Liver function test abnormal—Doxorubicin—sarcoma	0.000228	0.00206	CcSEcCtD
Ondansetron—Skin disorder—Etoposide—sarcoma	0.000227	0.00206	CcSEcCtD
Ondansetron—Hypokalaemia—Doxorubicin—sarcoma	0.000225	0.00203	CcSEcCtD
Ondansetron—Angina pectoris—Epirubicin—sarcoma	0.000225	0.00203	CcSEcCtD
Ondansetron—Urticaria—Mitoxantrone—sarcoma	0.000223	0.00202	CcSEcCtD
Ondansetron—Diarrhoea—Thiotepa—sarcoma	0.000223	0.00202	CcSEcCtD
Ondansetron—Body temperature increased—Mitoxantrone—sarcoma	0.000222	0.00201	CcSEcCtD
Ondansetron—Abdominal pain—Mitoxantrone—sarcoma	0.000222	0.00201	CcSEcCtD
Ondansetron—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000222	0.00201	CcSEcCtD
Ondansetron—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000222	0.00201	CcSEcCtD
Ondansetron—Diarrhoea—Dactinomycin—sarcoma	0.000221	0.002	CcSEcCtD
Ondansetron—SLC47A1—lymph node—sarcoma	0.000221	0.011	CbGeAlD
Ondansetron—Hypotension—Etoposide—sarcoma	0.000219	0.00198	CcSEcCtD
Ondansetron—KCNH2—bone marrow—sarcoma	0.000218	0.0109	CbGeAlD
Ondansetron—Dysuria—Epirubicin—sarcoma	0.000216	0.00195	CcSEcCtD
Ondansetron—Dizziness—Thiotepa—sarcoma	0.000215	0.00195	CcSEcCtD
Ondansetron—Asthma—Doxorubicin—sarcoma	0.000213	0.00193	CcSEcCtD
Ondansetron—Hypersensitivity—Vincristine—sarcoma	0.000213	0.00193	CcSEcCtD
Ondansetron—CYP3A4—hematopoietic system—sarcoma	0.000211	0.0106	CbGeAlD
Ondansetron—Paraesthesia—Etoposide—sarcoma	0.00021	0.0019	CcSEcCtD
Ondansetron—Dyspnoea—Etoposide—sarcoma	0.000209	0.00189	CcSEcCtD
Ondansetron—Somnolence—Etoposide—sarcoma	0.000208	0.00188	CcSEcCtD
Ondansetron—Angina pectoris—Doxorubicin—sarcoma	0.000208	0.00188	CcSEcCtD
Ondansetron—CYP2D6—hematopoietic system—sarcoma	0.000208	0.0104	CbGeAlD
Ondansetron—Hypersensitivity—Mitoxantrone—sarcoma	0.000207	0.00187	CcSEcCtD
Ondansetron—Asthenia—Vincristine—sarcoma	0.000207	0.00187	CcSEcCtD
Ondansetron—Vomiting—Thiotepa—sarcoma	0.000207	0.00187	CcSEcCtD
Ondansetron—Drowsiness—Epirubicin—sarcoma	0.000206	0.00186	CcSEcCtD
Ondansetron—Vomiting—Dactinomycin—sarcoma	0.000206	0.00186	CcSEcCtD
Ondansetron—Rash—Thiotepa—sarcoma	0.000205	0.00186	CcSEcCtD
Ondansetron—Dermatitis—Thiotepa—sarcoma	0.000205	0.00186	CcSEcCtD
Ondansetron—Headache—Thiotepa—sarcoma	0.000204	0.00185	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000204	0.00184	CcSEcCtD
Ondansetron—Rash—Dactinomycin—sarcoma	0.000204	0.00184	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Etoposide—sarcoma	0.000202	0.00183	CcSEcCtD
Ondansetron—Asthenia—Mitoxantrone—sarcoma	0.000202	0.00183	CcSEcCtD
Ondansetron—Fatigue—Etoposide—sarcoma	0.000202	0.00182	CcSEcCtD
Ondansetron—Pain—Etoposide—sarcoma	0.0002	0.00181	CcSEcCtD
Ondansetron—Constipation—Etoposide—sarcoma	0.0002	0.00181	CcSEcCtD
Ondansetron—Urinary tract infection—Epirubicin—sarcoma	0.0002	0.00181	CcSEcCtD
Ondansetron—Dysuria—Doxorubicin—sarcoma	0.0002	0.00181	CcSEcCtD
Ondansetron—Diarrhoea—Vincristine—sarcoma	0.000198	0.00179	CcSEcCtD
Ondansetron—Hepatobiliary disease—Epirubicin—sarcoma	0.000195	0.00176	CcSEcCtD
Ondansetron—Feeling abnormal—Etoposide—sarcoma	0.000193	0.00174	CcSEcCtD
Ondansetron—Diarrhoea—Mitoxantrone—sarcoma	0.000192	0.00174	CcSEcCtD
Ondansetron—Gastrointestinal pain—Etoposide—sarcoma	0.000191	0.00173	CcSEcCtD
Ondansetron—Dizziness—Vincristine—sarcoma	0.000191	0.00173	CcSEcCtD
Ondansetron—Drowsiness—Doxorubicin—sarcoma	0.00019	0.00172	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000189	0.00171	CcSEcCtD
Ondansetron—Bradycardia—Epirubicin—sarcoma	0.000188	0.0017	CcSEcCtD
Ondansetron—KCNH2—testis—sarcoma	0.000187	0.00934	CbGeAlD
Ondansetron—Urticaria—Etoposide—sarcoma	0.000186	0.00168	CcSEcCtD
Ondansetron—Haemoglobin—Epirubicin—sarcoma	0.000186	0.00168	CcSEcCtD
Ondansetron—Body temperature increased—Etoposide—sarcoma	0.000185	0.00167	CcSEcCtD
Ondansetron—Abdominal pain—Etoposide—sarcoma	0.000185	0.00167	CcSEcCtD
Ondansetron—Urinary tract infection—Doxorubicin—sarcoma	0.000185	0.00167	CcSEcCtD
Ondansetron—CYP2E1—lymphoid tissue—sarcoma	0.000185	0.00924	CbGeAlD
Ondansetron—Haemorrhage—Epirubicin—sarcoma	0.000185	0.00167	CcSEcCtD
Ondansetron—Vomiting—Vincristine—sarcoma	0.000184	0.00166	CcSEcCtD
Ondansetron—Rash—Vincristine—sarcoma	0.000182	0.00165	CcSEcCtD
Ondansetron—Dermatitis—Vincristine—sarcoma	0.000182	0.00165	CcSEcCtD
Ondansetron—Headache—Vincristine—sarcoma	0.000181	0.00164	CcSEcCtD
Ondansetron—Hepatobiliary disease—Doxorubicin—sarcoma	0.00018	0.00163	CcSEcCtD
Ondansetron—Vomiting—Mitoxantrone—sarcoma	0.000179	0.00162	CcSEcCtD
Ondansetron—Visual impairment—Epirubicin—sarcoma	0.000178	0.00161	CcSEcCtD
Ondansetron—Rash—Mitoxantrone—sarcoma	0.000177	0.0016	CcSEcCtD
Ondansetron—Dermatitis—Mitoxantrone—sarcoma	0.000177	0.0016	CcSEcCtD
Ondansetron—Headache—Mitoxantrone—sarcoma	0.000176	0.00159	CcSEcCtD
Ondansetron—Erythema multiforme—Epirubicin—sarcoma	0.000175	0.00158	CcSEcCtD
Ondansetron—Bradycardia—Doxorubicin—sarcoma	0.000174	0.00157	CcSEcCtD
Ondansetron—CYP2E1—tendon—sarcoma	0.000174	0.00869	CbGeAlD
Ondansetron—Eye disorder—Epirubicin—sarcoma	0.000173	0.00156	CcSEcCtD
Ondansetron—Hypersensitivity—Etoposide—sarcoma	0.000172	0.00156	CcSEcCtD
Ondansetron—Haemoglobin—Doxorubicin—sarcoma	0.000172	0.00155	CcSEcCtD
Ondansetron—Cardiac disorder—Epirubicin—sarcoma	0.000171	0.00155	CcSEcCtD
Ondansetron—Flushing—Epirubicin—sarcoma	0.000171	0.00155	CcSEcCtD
Ondansetron—Haemorrhage—Doxorubicin—sarcoma	0.000171	0.00155	CcSEcCtD
Ondansetron—Asthenia—Etoposide—sarcoma	0.000168	0.00152	CcSEcCtD
Ondansetron—Angiopathy—Epirubicin—sarcoma	0.000168	0.00152	CcSEcCtD
Ondansetron—Immune system disorder—Epirubicin—sarcoma	0.000167	0.00151	CcSEcCtD
Ondansetron—Mediastinal disorder—Epirubicin—sarcoma	0.000166	0.00151	CcSEcCtD
Ondansetron—Chills—Epirubicin—sarcoma	0.000166	0.0015	CcSEcCtD
Ondansetron—Pruritus—Etoposide—sarcoma	0.000166	0.0015	CcSEcCtD
Ondansetron—Arrhythmia—Epirubicin—sarcoma	0.000165	0.00149	CcSEcCtD
Ondansetron—Visual impairment—Doxorubicin—sarcoma	0.000165	0.00149	CcSEcCtD
Ondansetron—Erythema multiforme—Doxorubicin—sarcoma	0.000162	0.00146	CcSEcCtD
Ondansetron—Erythema—Epirubicin—sarcoma	0.000161	0.00145	CcSEcCtD
Ondansetron—Diarrhoea—Etoposide—sarcoma	0.00016	0.00145	CcSEcCtD
Ondansetron—Eye disorder—Doxorubicin—sarcoma	0.00016	0.00144	CcSEcCtD
Ondansetron—Flushing—Doxorubicin—sarcoma	0.000159	0.00143	CcSEcCtD
Ondansetron—Cardiac disorder—Doxorubicin—sarcoma	0.000159	0.00143	CcSEcCtD
Ondansetron—Flatulence—Epirubicin—sarcoma	0.000158	0.00143	CcSEcCtD
Ondansetron—Angiopathy—Doxorubicin—sarcoma	0.000155	0.0014	CcSEcCtD
Ondansetron—Dizziness—Etoposide—sarcoma	0.000155	0.0014	CcSEcCtD
Ondansetron—Immune system disorder—Doxorubicin—sarcoma	0.000154	0.0014	CcSEcCtD
Ondansetron—Mediastinal disorder—Doxorubicin—sarcoma	0.000154	0.00139	CcSEcCtD
Ondansetron—Chills—Doxorubicin—sarcoma	0.000153	0.00139	CcSEcCtD
Ondansetron—Arrhythmia—Doxorubicin—sarcoma	0.000153	0.00138	CcSEcCtD
Ondansetron—Vision blurred—Epirubicin—sarcoma	0.000151	0.00137	CcSEcCtD
Ondansetron—CYP1A2—liver—sarcoma	0.000151	0.00756	CbGeAlD
Ondansetron—Ill-defined disorder—Epirubicin—sarcoma	0.000149	0.00135	CcSEcCtD
Ondansetron—Vomiting—Etoposide—sarcoma	0.000149	0.00135	CcSEcCtD
Ondansetron—Erythema—Doxorubicin—sarcoma	0.000149	0.00135	CcSEcCtD
Ondansetron—Agitation—Epirubicin—sarcoma	0.000148	0.00134	CcSEcCtD
Ondansetron—Rash—Etoposide—sarcoma	0.000148	0.00133	CcSEcCtD
Ondansetron—Dermatitis—Etoposide—sarcoma	0.000147	0.00133	CcSEcCtD
Ondansetron—Headache—Etoposide—sarcoma	0.000147	0.00133	CcSEcCtD
Ondansetron—Flatulence—Doxorubicin—sarcoma	0.000147	0.00133	CcSEcCtD
Ondansetron—CYP3A5—liver—sarcoma	0.000146	0.00729	CbGeAlD
Ondansetron—Malaise—Epirubicin—sarcoma	0.000145	0.00131	CcSEcCtD
Ondansetron—Syncope—Epirubicin—sarcoma	0.000144	0.0013	CcSEcCtD
Ondansetron—CYP2E1—testis—sarcoma	0.000144	0.00719	CbGeAlD
Ondansetron—CYP2C9—liver—sarcoma	0.000143	0.00717	CbGeAlD
Ondansetron—Palpitations—Epirubicin—sarcoma	0.000142	0.00128	CcSEcCtD
Ondansetron—Loss of consciousness—Epirubicin—sarcoma	0.000141	0.00128	CcSEcCtD
Ondansetron—Cough—Epirubicin—sarcoma	0.00014	0.00127	CcSEcCtD
Ondansetron—Vision blurred—Doxorubicin—sarcoma	0.00014	0.00127	CcSEcCtD
Ondansetron—Convulsion—Epirubicin—sarcoma	0.000139	0.00126	CcSEcCtD
Ondansetron—Ill-defined disorder—Doxorubicin—sarcoma	0.000138	0.00125	CcSEcCtD
Ondansetron—Chest pain—Epirubicin—sarcoma	0.000137	0.00124	CcSEcCtD
Ondansetron—Agitation—Doxorubicin—sarcoma	0.000137	0.00124	CcSEcCtD
Ondansetron—Anxiety—Epirubicin—sarcoma	0.000136	0.00123	CcSEcCtD
Ondansetron—CYP2E1—liver—sarcoma	0.000136	0.0068	CbGeAlD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000136	0.00123	CcSEcCtD
Ondansetron—KCNH2—lymph node—sarcoma	0.000135	0.00677	CbGeAlD
Ondansetron—Discomfort—Epirubicin—sarcoma	0.000135	0.00122	CcSEcCtD
Ondansetron—Malaise—Doxorubicin—sarcoma	0.000134	0.00121	CcSEcCtD
Ondansetron—Dry mouth—Epirubicin—sarcoma	0.000134	0.00121	CcSEcCtD
Ondansetron—Syncope—Doxorubicin—sarcoma	0.000133	0.00121	CcSEcCtD
Ondansetron—Palpitations—Doxorubicin—sarcoma	0.000131	0.00119	CcSEcCtD
Ondansetron—Anaphylactic shock—Epirubicin—sarcoma	0.000131	0.00119	CcSEcCtD
Ondansetron—Loss of consciousness—Doxorubicin—sarcoma	0.000131	0.00118	CcSEcCtD
Ondansetron—Cough—Doxorubicin—sarcoma	0.00013	0.00117	CcSEcCtD
Ondansetron—Shock—Epirubicin—sarcoma	0.000129	0.00117	CcSEcCtD
Ondansetron—Convulsion—Doxorubicin—sarcoma	0.000129	0.00117	CcSEcCtD
Ondansetron—Nervous system disorder—Epirubicin—sarcoma	0.000129	0.00116	CcSEcCtD
Ondansetron—Tachycardia—Epirubicin—sarcoma	0.000128	0.00116	CcSEcCtD
Ondansetron—Skin disorder—Epirubicin—sarcoma	0.000127	0.00115	CcSEcCtD
Ondansetron—Chest pain—Doxorubicin—sarcoma	0.000127	0.00115	CcSEcCtD
Ondansetron—Anxiety—Doxorubicin—sarcoma	0.000126	0.00114	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000126	0.00114	CcSEcCtD
Ondansetron—Discomfort—Doxorubicin—sarcoma	0.000125	0.00113	CcSEcCtD
Ondansetron—Dry mouth—Doxorubicin—sarcoma	0.000124	0.00112	CcSEcCtD
Ondansetron—Hypotension—Epirubicin—sarcoma	0.000123	0.00111	CcSEcCtD
Ondansetron—Anaphylactic shock—Doxorubicin—sarcoma	0.000121	0.0011	CcSEcCtD
Ondansetron—Shock—Doxorubicin—sarcoma	0.000119	0.00108	CcSEcCtD
Ondansetron—Nervous system disorder—Doxorubicin—sarcoma	0.000119	0.00108	CcSEcCtD
Ondansetron—Tachycardia—Doxorubicin—sarcoma	0.000118	0.00107	CcSEcCtD
Ondansetron—Skin disorder—Doxorubicin—sarcoma	0.000118	0.00107	CcSEcCtD
Ondansetron—Paraesthesia—Epirubicin—sarcoma	0.000118	0.00107	CcSEcCtD
Ondansetron—Dyspnoea—Epirubicin—sarcoma	0.000117	0.00106	CcSEcCtD
Ondansetron—Somnolence—Epirubicin—sarcoma	0.000117	0.00105	CcSEcCtD
Ondansetron—CYP2D6—testis—sarcoma	0.000114	0.00569	CbGeAlD
Ondansetron—Hypotension—Doxorubicin—sarcoma	0.000113	0.00103	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Epirubicin—sarcoma	0.000113	0.00102	CcSEcCtD
Ondansetron—Fatigue—Epirubicin—sarcoma	0.000113	0.00102	CcSEcCtD
Ondansetron—Constipation—Epirubicin—sarcoma	0.000112	0.00101	CcSEcCtD
Ondansetron—Pain—Epirubicin—sarcoma	0.000112	0.00101	CcSEcCtD
Ondansetron—CYP3A4—liver—sarcoma	0.000109	0.00547	CbGeAlD
Ondansetron—Paraesthesia—Doxorubicin—sarcoma	0.000109	0.000986	CcSEcCtD
Ondansetron—Dyspnoea—Doxorubicin—sarcoma	0.000108	0.000979	CcSEcCtD
Ondansetron—Feeling abnormal—Epirubicin—sarcoma	0.000108	0.000978	CcSEcCtD
Ondansetron—Somnolence—Doxorubicin—sarcoma	0.000108	0.000976	CcSEcCtD
Ondansetron—CYP2D6—liver—sarcoma	0.000108	0.00538	CbGeAlD
Ondansetron—Gastrointestinal pain—Epirubicin—sarcoma	0.000107	0.00097	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000105	0.000948	CcSEcCtD
Ondansetron—Fatigue—Doxorubicin—sarcoma	0.000105	0.000947	CcSEcCtD
Ondansetron—Urticaria—Epirubicin—sarcoma	0.000104	0.000943	CcSEcCtD
Ondansetron—Constipation—Doxorubicin—sarcoma	0.000104	0.000939	CcSEcCtD
Ondansetron—Pain—Doxorubicin—sarcoma	0.000104	0.000939	CcSEcCtD
Ondansetron—Body temperature increased—Epirubicin—sarcoma	0.000104	0.000938	CcSEcCtD
Ondansetron—Abdominal pain—Epirubicin—sarcoma	0.000104	0.000938	CcSEcCtD
Ondansetron—Feeling abnormal—Doxorubicin—sarcoma	0.0001	0.000905	CcSEcCtD
Ondansetron—Gastrointestinal pain—Doxorubicin—sarcoma	9.92e-05	0.000898	CcSEcCtD
Ondansetron—Hypersensitivity—Epirubicin—sarcoma	9.66e-05	0.000874	CcSEcCtD
Ondansetron—Urticaria—Doxorubicin—sarcoma	9.64e-05	0.000872	CcSEcCtD
Ondansetron—Body temperature increased—Doxorubicin—sarcoma	9.59e-05	0.000868	CcSEcCtD
Ondansetron—Abdominal pain—Doxorubicin—sarcoma	9.59e-05	0.000868	CcSEcCtD
Ondansetron—Asthenia—Epirubicin—sarcoma	9.41e-05	0.000851	CcSEcCtD
Ondansetron—Pruritus—Epirubicin—sarcoma	9.28e-05	0.000839	CcSEcCtD
Ondansetron—Diarrhoea—Epirubicin—sarcoma	8.97e-05	0.000812	CcSEcCtD
Ondansetron—Hypersensitivity—Doxorubicin—sarcoma	8.94e-05	0.000809	CcSEcCtD
Ondansetron—Asthenia—Doxorubicin—sarcoma	8.71e-05	0.000788	CcSEcCtD
Ondansetron—Dizziness—Epirubicin—sarcoma	8.67e-05	0.000785	CcSEcCtD
Ondansetron—Pruritus—Doxorubicin—sarcoma	8.59e-05	0.000777	CcSEcCtD
Ondansetron—Vomiting—Epirubicin—sarcoma	8.34e-05	0.000754	CcSEcCtD
Ondansetron—Diarrhoea—Doxorubicin—sarcoma	8.3e-05	0.000751	CcSEcCtD
Ondansetron—Rash—Epirubicin—sarcoma	8.27e-05	0.000748	CcSEcCtD
Ondansetron—Dermatitis—Epirubicin—sarcoma	8.26e-05	0.000747	CcSEcCtD
Ondansetron—Headache—Epirubicin—sarcoma	8.22e-05	0.000743	CcSEcCtD
Ondansetron—Dizziness—Doxorubicin—sarcoma	8.03e-05	0.000726	CcSEcCtD
Ondansetron—Vomiting—Doxorubicin—sarcoma	7.72e-05	0.000698	CcSEcCtD
Ondansetron—Rash—Doxorubicin—sarcoma	7.65e-05	0.000692	CcSEcCtD
Ondansetron—Dermatitis—Doxorubicin—sarcoma	7.65e-05	0.000692	CcSEcCtD
Ondansetron—Headache—Doxorubicin—sarcoma	7.6e-05	0.000688	CcSEcCtD
